Anzeige
Mehr »
Login
Sonntag, 06.10.2024 Börsentäglich über 12.000 News von 690 internationalen Medien
Achtung Vervielfachung! URAN-AKTIEN starten durch …. Jetzt kaufen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
283 Leser
Artikel bewerten:
(1)

Prosthetic Heart Valve Market to Reach $30.3 billion, Globally, by 2035 at 11.1% CAGR: Allied Market Research

Rise in prevalence of structural heart valve diseases, increase in demand for minimally invasive procedures, surge in number of product approvals, and upsurge in geriatric population are the factors that drive the growth of the global prosthetic heart valve market.

PORTLAND, Ore., May 15, 2024 /PRNewswire/ -- Allied Market Research published a report, titled, "Prosthetic Heart Valve Market by Product (Mechanical Heart Valve, Tissue Heart Valve, and Transcatheter Heart Valve): Global Opportunity Analysis and Industry Forecast, 2024-2035". According to the report, the "prosthetic heart valve market" was valued at $8.6 billion in 2023, and is estimated to reach $30.3 billion by 2035, growing at a CAGR of 11.1% from 2024 to 2035.

Allied Market Research Logo

Request Sample of the Report on Prosthetic Heart Valve Market Forecast 2035 - https://www.alliedmarketresearch.com/request-sample/2176

Prime determinants of growth

Surge in prevalence of structural heart valve diseases, increase in demand for minimally invasive procedures, rise in number of product approvals, and upsurge in geriatric population are the major factors that drive the growth of the global prosthetic heart valve market. However, the high cost and risks associated with treatment procedures for prosthetic heart valves restricts market growth. Moreover, growth opportunities in emerging markets and technological advancements in heart valve replacement devices are expected to present new opportunities in the coming years.

Report coverage & details

Report Coverage

Details

Forecast Period

2023-2035

Base Year

2023

Market Size in 2023

$8.6 billion

Market Size in 2035

$30.3 billion

CAGR

11.1 %

No. of Pages in Report

218

Segments Covered

Product and Region

Drivers

Rise in prevalence of structural heart valve diseases


Surge in demand for minimally invasive procedures


Rise in geriatric population


Upsurge in product approvals for heart valve diseases treatment

Opportunities

Growth opportunities in emerging markets


Technological advancements in heart valve replacement devices

Restraint

High costs and risks associated with treatment procedures


Want to Explore More, Connect to our Analyst-
https://www.alliedmarketresearch.com/connect-to-analyst/2176

The transcatheter heart valve segment to maintain its leadership status throughout the forecast period

By product, the transcatheter heart valve segment held the largest market share in 2023, accounting for nearly three-fourths of the global prosthetic heart valve market revenue and is estimated to maintain its leadership status throughout the forecast period. This segment is expected to register the highest CAGR of 11.5% during the forecast period. This is attributed to rise in demand for minimally invasive surgical procedures and availability of advanced transcatheter heart valves.

North America to maintain its dominance by 2035

By region, North America held the largest market share in terms of revenue in 2023, accounting for more than two-fifths the global prosthetic heart valve market revenue and is likely to dominate the market during the forecast period. This is attributed to the increase in the geriatric population in North America, which has led to a higher prevalence of heart diseases, leading to increased demand for prosthetic heart valves. However, Asia-Pacific is expected to witness the fastest CAGR of 11.9% from 2024 to 2035. This is attributed to the rise in prevalence of heart valve disease, surge in healthcare expenditure, and upsurge in awareness about the importance of early detection & treatment of heart valve diseases.

For Purchase Enquiry - https://www.alliedmarketresearch.com/purchase-enquiry/2176

Leading Market Players

  • MERIL LIFE SCIENCES PVT. LTD.
  • Boston Scientific Corporation
  • Shockwave Medical
  • Edwards Lifesciences Corporation
  • JenaValve Technology, Inc.
  • Abbott Laboratories
  • Medtronic Plc
  • Livanova Plc
  • Labcor Laboratorios Ltda
  • Artivion, Inc.

The report provides a detailed analysis of these key players in the global prosthetic heart valve market. These players have adopted strategies such as an acquisition, agreement, product launch, product approval, and rebranding to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to highlight the competitive scenario.

AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int'l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on: LinkedIn

Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/prosthetic-heart-valve-market-to-reach-30-3-billion-globally-by-2035-at-11-1-cagr-allied-market-research-302146040.html

© 2024 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.